Literature DB >> 31204037

Prevalence and Prognostic Implications of Right Ventricular Dysfunction in Patients With Hypertrophic Cardiomyopathy.

Yasmine L Hiemstra1, Philippe Debonnaire2, Marianne Bootsma1, Martin J Schalij1, Jeroen J Bax1, Victoria Delgado1, Nina Ajmone Marsan3.   

Abstract

Right ventricular (RV) dysfunction is a well-known prognostic factor in several cardiac diseases. However, the prevalence of RV dysfunction in hypertrophic cardiomyopathy (HC) is unclear and its prognostic value is unknown. This study aims at addressing these issues assessing RV function with speckle tracking echocardiography. In 267 HC patients (52 ± 15 years, 68% male), standard and advanced echocardiographic measurements of RV function were performed including RV 4-chamber longitudinal strain (RV4CLS) and RV free wall longitudinal strain (RVFWLS). The primary end point was all-cause mortality and heart failure development. RV dysfunction was observed in 9% of patients based on tricuspid annular plane systolic excursion (≤17 mm), 5% based on fractional area change (<35%), 23% based on RVFWLS ≥-19%, 39% based on RVFWLS ≥-23%, and 55% based on RV4CLS ≥-20%. In total 59 (22%) patients reached the primary end point during a median follow-up of 6.7 (interquartile range 4.2 to 9.8) years. Kaplan-Meier survival curve showed a significant worse survival free of the end point for patients with impaired RV4CLS ≥-20% versus patients with preserved RV4CLS <-20% (log-rank 7.0, p = 0.008) and for patients with impaired RVFWLS ≥-19% versus patients with preserved RVFWLS <-19% (log-rank 4.4, p = 0.037). Multivariable Cox regression analysis showed that E/E' (hazards ratio [HR] 2.26 [1.30 to 3.92], p = 0.004), left ventricular global longitudinal strain LV GLS (HR 1.08 (1.01 to 1.17), p = 0.034) and RV4CLS (HR 1.08 (1.02 to 1.15), p = 0.007) were independently associated with the primary end point. In conclusion, RV dysfunction as measured by longitudinal strain is relatively frequent in HC patients. Impaired RV4CLS is - together with LV GLS and E/E' - associated with adverse outcome, which may indicate a more severe form of HC.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31204037     DOI: 10.1016/j.amjcard.2019.05.021

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  6 in total

1.  Predictors of right ventricular function and size in patients with hypertrophic cardiomyopathy.

Authors:  Mateusz Śpiewak; Mariusz Kłopotowski; Łukasz Mazurkiewicz; Ewa Kowalik; Joanna Petryka-Mazurkiewicz; Barbara Miłosz-Wieczorek; Anna Klisiewicz; Adam Witkowski; Magdalena Marczak
Journal:  Sci Rep       Date:  2020-12-03       Impact factor: 4.379

2.  Right Ventricular Diastolic Performance in Patients With Chronic Thromboembolic Pulmonary Hypertension Assessed by Echocardiography.

Authors:  Hong Meng; Wu Song; Sheng Liu; David Hsi; Lin-Yuan Wan; Hui Li; Shan-Shan Zheng; Zhi-Wei Wang; Rong Ren; Wei-Xian Yang
Journal:  Front Cardiovasc Med       Date:  2021-11-25

Review 3.  The Prognostic Importance of Right Ventricular Longitudinal Strain in Patients with Cardiomyopathies, Connective Tissue Diseases, Coronary Artery Disease, and Congenital Heart Diseases.

Authors:  Marijana Tadic; Johannes Kersten; Nicoleta Nita; Leonhard Schneider; Dominik Buckert; Birgid Gonska; Dominik Scharnbeck; Tilman Dahme; Armin Imhof; Evgeny Belyavskiy; Cesare Cuspidi; Wolfgang Rottbauer
Journal:  Diagnostics (Basel)       Date:  2021-05-26

4.  Hypertrophic cardiomyopathies requiring more monitoring for less atrial fibrillation-related complications: a clustering analysis based on the French registry on hypertrophic cardiomyopathy (REMY).

Authors:  Marion Hourqueig; Guillaume Bouzille; Albert Hagège; Erwan Donal; Mariana Mirabel; Olivier Huttin; Thibaud Damy; Fabien Labombarda; Jean-Christophe Eicher; Philippe Charron; Gilbert Habib; Patricia Réant
Journal:  Clin Res Cardiol       Date:  2021-05-27       Impact factor: 5.460

5.  Palpitation was associated with clinical outcomes in patients with hypertrophic cardiomyopathy.

Authors:  Tingting Hu; Tao Wang; Xiwen Zhang
Journal:  Sci Rep       Date:  2020-09-10       Impact factor: 4.379

6.  Disease Progression of Hypertrophic Cardiomyopathy: Modeling Using Machine Learning.

Authors:  Matej Pičulin; Tim Smole; Bojan Žunkovič; Enja Kokalj; Marko Robnik-Šikonja; Matjaž Kukar; Dimitrios I Fotiadis; Vasileios C Pezoulas; Nikolaos S Tachos; Fausto Barlocco; Francesco Mazzarotto; Dejana Popović; Lars S Maier; Lazar Velicki; Iacopo Olivotto; Guy A MacGowan; Djordje G Jakovljević; Nenad Filipović; Zoran Bosnić
Journal:  JMIR Med Inform       Date:  2022-02-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.